Fayez Sarofim & Co Cuts Exposure as Flow Ratio Signals Sharp Distribution

Fayez Sarofim & Co’s most recent 13F reveals a portfolio in contraction mode. A flow ratio of 0.34x—well below the 0.7x threshold for significant distribution—indicates that new and increased positions are only a third of the value being sold or reduced. The conviction ratio of 0.25, under the 0.4 cut‑off, confirms that the fund is trimming rather than reinforcing existing stakes.

Quarter‑over‑quarter, AUM fell to $41.66 billion, a drop of $1.46 billion (‑3.4%). This decline follows a year‑to‑date rise of $518.2 million, suggesting that the recent pullback is driven by active rebalancing rather than market depreciation. Position‑flow data shows 45 positions increased against 135 decreased, reinforcing the distribution narrative.

The most material allocation change centers on Alphabet Inc., where the fund added 190,134 shares, lifting the holding’s market value by $579.3 million—the largest absolute increase across the portfolio. This addition pushes Alphabet to a 5.9% weighting within the fund, underscoring a selective bet on the search‑engine giant despite broader trimming.

Conversely, the biggest single reduction targets Microsoft Corp. The fund shed 150,904 shares, cutting the position’s value by $362.7 million. Microsoft now sits at a 8.9% weighting, down from its prior level but still within the top‑two concentration tier. Procter & Gamble followed with a 32.5% share reduction, erasing $259.6 million of value, while Novo‑Nordisk and Union Pacific each lost over $150 million in market exposure.

The fund’s top‑ten holdings continue to account for 47.7% of assets, just shy of the 50% concentration trigger that would label the portfolio as highly concentrated. Apple, Microsoft, Alphabet, Amazon, Philip Morris International, NVIDIA, Meta Platforms, Coca‑Cola, Visa, and JPMorgan Chase together represent the bulk of exposure, leaving roughly half of the AUM spread across 287 other positions.

New entries are modest in scale. The fund opened six positions, the largest being Banco Bilbao Vizcaya‑Sp ADR at $395 k, and a 1,200‑share stake in the Invesco Nasdaq 100 ETF valued at $304 k. These additions are dwarfed by the $8.7 million exit from TotalEnergies SE and the $6.2 million sale of Kellanova, reflecting a focus on pruning rather than expanding the universe.

Sectorally, the fund trimmed exposure in consumer staples, energy, and telecommunications while modestly boosting semiconductor and biotech exposure. Notable increases include Taiwan Semiconductor (+21.5% shares, +$174.7 million) and AstraZeneca (+9.4% shares, +$92.7 million). The fund also boosted its stake in the SPDR S&P 500 ETF Trust by a staggering 249.1%, adding $51.6 million, a move that may serve as a cash‑efficient hedge amid the broader sell‑off.

Overall, the filing paints a picture of a hedge fund that is actively rebalancing toward a leaner, more selective core. The low flow ratio and conviction ratio signal that the recent AUM dip is not a passive market effect but a deliberate reduction of exposure, especially in large‑cap tech names that have appreciated significantly over the past year. Investors should watch whether the fund maintains its selective additions—particularly the sizable Alphabet bet—or continues to pare back its remaining high‑weight positions in the coming quarters.